Albemarle (ALB) Stock Surges 11% as Q1 Earnings Crush Expectations Amid Lithium Price Rebound

Table of Contents Albemarle shares soared 11% to $213 during early Thursday trading sessions following the lithium manufacturer’s announcement of first-quarter results that dramatically exceeded analyst projections. Albemarle Corporation, ALB The Charlotte-based company delivered adjusted earnings per share of $2.95, substantially outpacing the analyst consensus forecast of $1.19. Quarterly revenue totaled $1.4 billion, surpassing expectations of $1.3 billion and representing a 33% gain compared to the corresponding quarter last year. Adjusted EBITDA registered at $664 million — exceeding the consensus projection of $444 million by 50%. This represents a remarkable 148% year-over-year increase. $ALB | Albemarle Corp., Q1-2026 Earning Report pic.twitter.com/la6gjYPX8r — Hardik Shah (@AIStockSavvy) May 6, 2026 During the same quarter last year, Albemarle recorded a per-share loss of 18 cents with revenue totaling $1.1 billion. The financial reversal has been dramatic. The underlying catalyst for these strong results is the recovery in lithium pricing. Current benchmark prices hover around $26,000 per metric ton. A year earlier, these prices languished below $10,000. Prices had climbed above $85,000 per metric ton in late 2022 before plummeting due to excess supply and weakening electric vehicle demand. The price recovery stems from expanding demand in energy storage applications, which has helped stabilize market dynamics. Albemarle specifically highlighted increased volumes and improved pricing from its energy storage customer base. The Energy Storage and lithium segments achieved margins of approximately 62% during the quarter, significantly surpassing the consensus forecast of around 45%. Favorable timing on spodumene contributed to this margin outperformance. Both the Specialties and Catalyst/Other divisions exceeded projections by roughly $20 million each. The company reaffirmed its full-year guidance, which now incorporates approximately $80 million in costs related to Middle East logistics and supply chain disruptions. Looking toward Q2, management anticipates sequential margin compression due to unfavorable spodumene timing effects and ongoing supply chain expenses. The company achieved $17 per LCE during Q1 and projects this metric to improve throughout the remainder of the year. UBS maintained its Buy rating and $230 price objective on ALB shares following the quarterly report. The firm highlighted that the earnings beat was comprehensive across all business segments. Citi analyst Patrick Cunningham noted that Q2 EBITDA should demonstrate sequential growth across both Energy Storage and Specialties divisions — an observation he characterized as positive for the investment community. Based on Q1’s average lithium pricing, Albemarle leadership indicated they would anticipate full-year revenue of approximately $5.85 billion and EBITDA near $2.5 billion. Current Wall Street consensus models project $5.8 billion in sales and $2.3 billion in EBITDA for 2026. The company’s lithium volume guidance remains steady at flat year-over-year levels, despite potential headwinds from possible production reductions at the Greenbushes facility. UBS suggested this outlook could prove more favorable than anticipated if ultimately validated. Prior to Wednesday’s closing price of $193.58, ALB had already climbed approximately 37% during 2026 and skyrocketed 236% over the trailing twelve months. The stock traded above $325 in late 2022 during the peak of lithium pricing. Albemarle generated EBITDA of $3.5 billion in 2022 and $1.1 billion in 2025. The Q1 2026 EBITDA figure of $664 million suggests a substantially improved performance trajectory for the remainder of the fiscal year.